Medtech Products

18 recalls Categories: Other Drugs, Over-the-Counter

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Jul 26, 2019 Other Drugs Nationwide View Details →

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Jul 26, 2019 Other Drugs Nationwide View Details →

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Jul 26, 2019 Other Drugs Nationwide View Details →

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Jul 26, 2019 Other Drugs Nationwide View Details →

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Jul 26, 2019 Other Drugs Nationwide View Details →

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Jul 26, 2019 Other Drugs Nationwide View Details →

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Jul 26, 2019 Other Drugs Nationwide View Details →

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Jul 26, 2019 Other Drugs Nationwide View Details →

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Jul 26, 2019 Other Drugs Nationwide View Details →

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Jul 26, 2019 Other Drugs Nationwide View Details →

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Jul 26, 2019 Other Drugs Nationwide View Details →

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Jul 26, 2019 Other Drugs Nationwide View Details →

CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Jul 26, 2019 Other Drugs Nationwide View Details →

Incorrect/undeclared excipients: Kit carton bear incorrect labeling for two of the five items contained within the kit.

Mar 7, 2019 Other Drugs Nationwide View Details →

Marketed without an approved NDA/ANDA: The distributed units of Monistat 1 Simple Cure include only the 1200 mg vaginal suppository; the approved NDA requires both a 1200 mg vaginal suppository and the 2% topical cream.

Apr 10, 2015 Over-the-Counter Nationwide View Details →